Browsing publications by Julie Errington

Newcastle AuthorsTitleYearFull text
Dr Gareth Veal
Julie Errington
Sophie Rowbotham
Nicola Illingworth
Dr Ghada Malik
et al.
Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma2013
Julie Errington
Professor Alan Boddy
Dr Gareth Veal
Mike Cole
Pharmacokinetics of cyclophosphamide and its metabolites in pediatric patients receiving high-dose myeloablative therapy2011
Julie Errington
Professor Alan Boddy
Dr Gareth Veal
Mike Cole
Pharmacokinetics of high-dose cyclophosphamide and its metabolites in paediatric patients2011
Dr Gareth Veal
Julie Errington
Professor Andrew Pearson
Professor Alan Boddy
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients2010
Julie Errington
Professor Alan Boddy
Dr Gareth Veal
Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma2009
Dr Gareth Veal
Julie Errington
Dr Michael Tilby
Professor Alan Boddy
Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours2007
Professor Alan Boddy
Melanie Griffin
Julie Errington
Dr Gareth Veal
Dosing of cancer patients with low or absent renal function2007
Dr Gareth Veal
Mike Cole
Geoffrey Taylor
Julie Errington
Professor Alan Boddy
et al.
Pharmacogenetics and metabolism of cyclophosphamide in paediatric cancer patients2007
Dr Gareth Veal
Mike Cole
Julie Errington
Professor Alan Boddy
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - A study of the United Kingdom Children's Cancer Study Group2007
Dr Gareth Veal
Julie Errington
Huw Thomas
Professor Alan Boddy
Biliary excretion of etoposide in children with cancer2006
12